The Pharma Data

MAY 15, 2023

Development of the biosimilars will ramp-up over the coming 12-18 months.” Just – Evotec Biologics has developed an optimized proprietary ecosystem for cost-efficient, state-of-the-art drug development and manufacturing. Work is set to begin this year, with full operations provisionally planned for late 2026.

Biosimilars 40

Biosimilars Production Government Clinical Trials 40

Agency IQ

AUGUST 23, 2024

The office, which is responsible for directly reviewing and regulating medical devices and diagnostics, was established under a major restructuring of CDRH in 2018-2019 as part of CDRH’s “Total Product Lifecycle (TPLC)” approach. There are several high-level takeaways from these updates for drug developers.

FDA 40

FDA Laboratories Regulations Clinical Trials 40

Agency IQ

JUNE 9, 2023

What will the orphan drug market exclusivity haircut mean for industry? Just over a month ago, the European Commission released its proposal for the new pharmaceutical directive and regulation. Other orphan drugs, which, by definition, address an unmet medical need, “only” receive 9 years of market exclusivity.

Marketing 40

Marketing Regulations Biosimilars Drugs 40

Agency IQ

AUGUST 16, 2024

By Amanda Conti | Aug 13, 2024 10:00 PM CDT Regulatory context: Psychedelic regulation and drug development A growing body of evidence suggests that psychedelics may provide clinical benefit for certain purposes, especially mental health conditions. The study is planned to begin in 2026 and conclude in 2028.

FDA 40

FDA Trials Therapies Regulations 40

Perficient: Drug Development

SEPTEMBER 27, 2023

Much of this record-breaking adoption is a result of the unnatural demand caused by regulations. While these regulations and increased supply have improved adoption in some states, this approach also means that consumers in other states have less inventory to choose from and longer wait times.

Regulations 59

Regulations Marketing Production Government 59

Agency IQ

FEBRUARY 15, 2024

If you’re looking for something specific, we recommend using the search function in your browser (Ctrl-F) to look for keywords of interest.

FDA 40

FDA Science Biosimilars Clinical Trials 40

Perficient: Drug Development

NOVEMBER 12, 2024

Health insurers are always seeking access to actionable information about their members while adhering to data privacy laws and regulations. As the saying goes, diamonds are made under pressure, and the most impactful opportunities are often those that challenge leaders the most.

Engineering 105

Engineering Regulations 105

Perficient: Drug Development

NOVEMBER 21, 2024

The first compliance deadline of April 1, 2026, impacts the largest organizations. Under this ruling, banks, credit unions, credit card issuers, and other financial service providers must enhance consumer access to personal financial data. The ruling demands action from all non-depository firms (e.g.,

Compliance 52

Compliance Engineering Regulations Production 52

Perficient: Drug Development

MARCH 20, 2025

Balancing Innovation and Daily Operations Aileen brought a unique perspective from the highly regulated insurance and annuity space. Even in a regulated environment, were able to see progress that way. We hope to see you again at Adobe Summit 2026. So, I have our extended leadership team really drive new projects.

Regulations 52

Regulations Marketing International 52